# Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage

> **NCT01878136** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Subarachnoid Hemorrhage
- Cerebral Vasospasm
- Cerebral Aneurysm
- Hydrocephalus

## Interventions

- **DRUG:** Tissue Plasminogen Activator

## Key facts

- **NCT ID:** NCT01878136
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Time constraints
- **Last updated:** 2015-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878136, "Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01878136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
